For its report, analysts at Wells Fargo reviewed PriceRx data from August.
Here are four report findings:
1. The cost of 48 drugs went down in August. In July, 32 drug prices were lowered.
2. The 60 price hikes ranged from 486 percent to 1.6 percent, with a median increase of 9.9 percent.
3. The 48 drug price decreases ranged from 1.5 percent to 88 percent, with a median decrease of 38.6 percent.
4. Seven drugs increased in price by 100 percent or more. Those drugs included: FLUoxetine, Nitrofurantoin, Irbesartan-Hydrochlorothiazide, Valsartan, Thiamine, DilTIAZem and Ondansetron. Many of these drugs are generics.
More articles on pharmacy:
Hospitals mark up drugs by 479%: 6 report findings
6 latest drug, medical device recalls
US-Mexico trade deal grants drugmakers 10 years of patent exclusivity on biologics
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
